• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Opdivo (nivolumab) - Articles and news items

N is for Nivolumab

Blog / 1 December 2016 / Niamh Louise Marriott, Digital Editor

N is for Nivolumab – the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest research…

SMC ‘U-turn’ offers lifeline to Scottish skin cancer patients

Industry news / 8 August 2016 / Bristol-Myers Squibb

The SMC initially refused access to nivolumab for Scottish patients, having taken a different view to the National Institute for Health and Care Excellence (NICE), which approved it to treat patients in England and Wales. However, following a review of additional evidence, the SMC decision has been reversed, bringing access in Scotland on par with the rest of the UK…

 

Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +